ArticleInternational journal of cardiology. Heart & vasculature2021
Burden of Ischemic Heart Disease in Central Asian Countries, 1990-2017.
Article in International journal of cardiology. Heart & vasculature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Burden of Cardiovascular Disease in Asian Countries, 1990-2021.JACC. Asia · 2026Article
- Burden of Ischemic Heart Disease in Central Asia from 1990 to 2021: A Systematic Analysis of the Global Burden of Disease Study 2021.International journal of environmental research and public health · 2026Article
- Spatial Epidemiology of the Ischemic Heart Disease-Asthma Comorbidity: A Global Analysis of Burden Patterns, Risk Drivers, and a Composite Risk Index.Risk management and healthcare policy · 2026Article
- Digital Mapping of Central Asian Foods: Towards a Standardized Visual Atlas for Nutritional Research.Nutrients · 2025Article
- Mortality trends in Kazakhstan: insights from a million of deaths from 2014 to 2022.BMC public health · 2025Article
- Global Burden of Early-Onset Ischemic Heart Disease, 1990 to 2019.JACC. Advances · 2025Article
- Global, regional, and national burden and risk factors of ischemic heart disease, 1990-2021: an analysis of the global burden of disease study.Frontiers in public health · 2025Article
- Article
- Mortality Rate and Years of Life Lost Due to Ischemic Heart Disease in Southern Iran between 2004 and 2019: A Population-Based Study.Archives of Iranian medicine · 2024Article
- Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019.European heart journal. Quality of care & clinical outcomes · 2024Article
- Assessing Global, Regional, and National Time Trends and Associated Risk Factors of the Mortality in Ischemic Heart Disease Through Global Burden of Disease 2019 Study: Population-Based Study.JMIR public health and surveillance · 2024Article
- The mortality burden related to COVID-19 in 2020 and 2021 - years of life lost and excess mortality in 13 countries and sub-national regions in Southern and Eastern Europe, and Central Asia.Frontiers in public health · 2024Article
- Diagnostic and Therapeutic Strategies for Stable Coronary Artery Disease Following the ISCHEMIA Trial.JACC. Asia · 2023Review
- The burden of ischemic heart disease and the epidemiologic transition in the Eastern Mediterranean Region: 1990-2019.PloS one · 2023Article
- Incidence, mortality and disability-adjusted life years of acute myocardial infarction in Kazakhstan: data from unified national electronic healthcare system 2014-2019.Frontiers in cardiovascular medicine · 2023Article
- Risk assessment of dietary factors in global pattern of ischemic heart disease mortality and disability-adjusted life years over 30 years.Frontiers in nutrition · 2023Article
- Obesity, Burden of Ischemic Heart Diseases and Their Ecological Association: The Case of Uzbekistan.International journal of environmental research and public health · 2022Article
- The Global Burden of Diseases attributed to high low-density lipoprotein cholesterol from 1990 to 2019.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe burden of ischemic heart disease (IHD) is high. There is limited information on the burden of IHD in identified high risk areas like Central Asia (CA) which is comprised of Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Turkmenistan, Mongolia, Uzbekistan and Tajikistan. This study addresses the burden of IHD in CA at the regional and country levels.
methodsUsing data from the latest iteration of the Global Burden of Disease Study (GBD), this study provides age-adjusted mortality, prevalence, and Disability Adjusted Life Years (DALYs) of IHD by sex in the CA region, and national levels for countries in this region from 1990 to 2017.
resultsThe CA region has a higher IHD burden than the rest of the world over the studied period. Amongst the countries within this region, age-standardized mortality and DALY rates in Uzbekistan are the highest not only in CA but worldwide, while Armenia consistently has the lowest IHD burden in CA. Unhealthy diet, high systolic blood pressure and LDL-cholesterol are the risk factors with the highest attributable IHD DALYs.
conclusionIncreasing burden of IHD over time in CA can be partially explained by the economic crisis in the 1990
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.